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ABSTRACT Mast cells (MCs) are critical mediators of inﬂammation; however, their
microbicidal activity against invading pathogens remains largely unknown. Here, we
describe a nonpreviously reported antibacterial mechanism used by MCs against
Coxiella burnetii, the agent of Q fever. We show that C. burnetii interaction with MCs
does not result in bacterial uptake but rather induces the formation of extracellular
actin ﬁlaments named cytonemes. MC cytonemes express cathelicidin and neutro-
phil elastase and mediate the capture and destruction of entrapped bacteria. We
provide evidence that MC cytoneme formation and microbicidal activity are depen-
dent on the cooperation of the scavenger receptor CD36 and Toll-like receptor 4.
Taken together, our results suggest that MCs use an extracellular sophisticated
mechanism of defense to eliminate intracellular pathogens, such as C. burnetii, be-
fore their entry into host cells.
IMPORTANCE Mast cells (MCs) are found in tissues that are in close contact with ex-
ternal environment, such as skin, lungs, or intestinal mucosa but also in the placenta
during pregnancy. If their role in mediating allergic conditions is established, several
studies now highlight their importance during infection with extracellular patho-
gens. This study showed a new and effective antimicrobial mechanism of MCs
against Coxiella burnetii, an intracellular bacterium whose infection during pregnancy
is associated with abortion, preterm labor, and stillbirth. The data reveal that in re-
sponse to C. burnetii, MCs release extracellular actin ﬁlaments that contain antimicro-
bial agents and are capable to trap and kill bacteria. We show that this mechanism
is dependent on the cooperation of two membrane receptors, CD36 and Toll-like re-
ceptor 4, and may occur in the placenta during pregnancy by using ex vivo placen-
tal MCs. Overall, this study reports an unexpected role for MCs during infection with
intracellular bacteria and suggests that MC response to C. burnetii infection is a pro-
tective defense mechanism during pregnancy.
KEYWORDS CD36, Coxiella burnetii, mast cells, TLR4, cytonemes
Mast cells (MCs) are hematopoietic cells residing in tissues that occupy a strategicposition at host-environment interfaces, such as skin and mucosae. They are
characterized by a high content of electron-dense secretory granules containing high-
performance mediators, such as histamine, amines, serotonin, and proteases, such as
tryptase and chymase, and express CD117 (c-kit) and IgE (FcR1) receptors (1). They are
well-known as immune effectors of anaphylaxis, but their role in defending against
pathogens is emerging. MCs contribute to antibacterial immunity via multiple mech-
anisms. They are equipped with microbial sensors, such as Toll-like receptors (TLRs),
including TLR2 and TLR4, and are involved in the recognition of Gram-positive and
-negative bacteria (2–4). In response to lipopolysaccharide (LPS) or bacterial pathogens,
MCs release inﬂammatory cytokines that mediate the recruitment of immune cells and
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secrete antimicrobial agents, including cathelicidin (LL-37) and neutrophil elastase (5).
MCs are able to ingest and kill extracellular bacteria, such as Staphylococcus aureus,
through an endosome-lysosome pathway (6) or to use an extracellular antimicrobial
mechanism consisting of the release of extracellular traps (ETs) (7). Similarly to those
formed by neutrophils, these ETs are composed of antimicrobial peptide-lined DNA
projections, allowing the rapid immobilization and killing of microorganisms (7).
Coxiella burnetii is an intracellular bacterium responsible for Q fever, an acute
infectious disease that may become persistent in speciﬁc clinical contexts (8). In
myeloid cells, such as monocytes/macrophages and dendritic cells, C. burnetii survives
and replicates, but it has nevertheless been shown to infect other cell types, including
trophoblasts and adipocytes (9–12). C. burnetii is recognized by myeloid cells through
v3 integrin and TLR2/TLR4-dependent mechanism, leading to cytokine production
and cytoskeleton reorganization (13, 14). C. burnetii is also able to subvert immune
responses by interfering with uptake mechanisms and phagosome biogenesis (15),
stimulating the production of interleukin-10 (IL-10), and promoting the expansion of
regulatory T cells (13).
In the present study, we report that MCs were microbicidal for the intracellular
pathogen C. burnetii through a nonpreviously reported mechanism. Indeed, MCs have
released cytonemes consisting of long extensions of F-actin enriched with cathelicidin
and neutrophil elastase. These structures trapped and killed C. burnetii organisms.
Cytoneme-mediated killing of C. burnetii was under the control of the cross talk
between TLR4 and CD36. These results suggest that MCs have shaped an extracellular
sophisticated mechanism of defense to eliminate intracellular pathogens before their
entry in immune cells.
RESULTS
MCs kill C. burnetii through an extracellular mechanism. HMC-1.2 cells were
incubated with C. burnetii (50 bacteria per cell) for different periods of time, and the
number of bacterial DNA copies was determined by qPCR. After 3 h of infection, more
than 10 (7) C. burnetii DNA copies were detected. This number markedly decreased by
90% after 24 and 48 h (Fig. 1A). We questioned whether the decrease in the number of
bacterial DNA copies reﬂected the uptake and elimination of bacteria by MCs. We
assessed the uptake of C. burnetii by confocal microscopy, using S. aureus as the control.
S. aureus organisms were found within MCs at 3 h postinfection (p.i.), and the bacterial
burden increased at 24 h p.i. (Fig. 1B). In contrast, no C. burnetii organisms were found
within MCs at 3 and 24 h p.i, as opposed to monocytes which are permissive cells for
C. burnetii (see Fig. S1 in the supplemental material) as we previously described (16). It
is noteworthy that some C. burnetii organisms were observed at the surfaces of MCs
with intense F-actin rearrangements (Fig. 1B). The decreased number of C. burnetii DNA
copies and the defective uptake of bacteria suggested that an extracellular antimicro-
bial mechanism was employed by MCs to eliminate C. burnetii. Since ETs are used by
neutrophils and MCs to eliminate different types of bacteria (7), we quantiﬁed the
release of ETs in response to C. burnetii and S. aureus and used PMA as a positive
control. In neutrophils, C. burnetii and S. aureus induced a release of ETs similar to that
induced by PMA (Fig. 1C). In MCs, S. aureus triggered intense formation of ETs as in
neutrophils, whereas C. burnetii induced the release of few ETs (Fig. 1D). Therefore, we
wondered whether these rare traps were sufﬁcient to eliminate C. burnetii organisms.
For that purpose, we treated C. burnetii-incubated MCs with DNase, which is known to
disrupt ETs (17). This treatment did not increase the number of intracellular C. burnetii
DNA copies, suggesting that another extracellular mechanism is involved in the trap-
ping and elimination of C. burnetii by MCs (Fig. 1E). Taken together, these results
suggested that MCs use an ET-independent extracellular mechanism to kill C. burnetii.
C. burnetii induces the formation of cytonemes by MCs. As C. burnetii markedly
remodeled MC cytoskeleton, we analyzed the F-actin rearrangements induced by
bacteria. We observed the release of extracellular thread-like membrane actin ﬁlaments
(Fig. 2A). These structures were predominantly linear and distinct from pseudopods.
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FIG 1 Extracellular killing of C. burnetii. HMC-1.2 cells (1 106) were incubated with C. burnetii (50 bacteria per cell) for different
periods of time. (A) After the cells were washed, the number of C. burnetii DNA copies was determined by qPCR. (B) Confocal
sections of MCs incubated with S. aureus (top panel) or C. burnetii (bottom panel). Bacteria (red), F-actin (green), nucleus (blue),
and cytoskeletal reorganization (white arrows) are indicated. Bacteria located on the MC membrane are represented by yellow
arrows. (C and D) The extracellular traps released by neutrophils or MCs incubated with PMA, C. burnetii, or S. aureus for 3 h were
observed (DNA in blue and F-actin in green) (C) and quantiﬁed by evaluating the release of ﬂuorescent DNA (D). The results,
expressed as relative to PMA-stimulated cells, are the means plus standard deviations (SD) (error bars) for triplicate samples from
at least three independent experiments. **, P 0.01. (E) The number of C. burnetii DNA copies was determined by qPCR in MCs
incubated with bacteria for 3 h and then treated with 50 U/ml DNase for 10 min to eliminate ETs. The results are expressed as the
means plus SD for triplicate samples from at least three independent experiments. *, P 0.05.
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They measured up to 200 m in length and were composed of F-actin and tubulin
(Fig. 2B), suggesting that they were similar to the cytonemes produced by MCs as
previously described (18). The cytonemes appeared 15 min after C. burnetii stimulation;
the number of cytonemes reached a maximum between 3 and 6 h (50%) and
decreased thereafter (Fig. 2C). Several strains of C. burnetii have been described: they
include the Nine Mile strain (the reference strain) and Guyana strain (the most virulent).
We previously observed intense cell projections from monocytes stimulated by virulent
C. burnetii compared to the avirulent variant (19). We wondered whether cytoneme
formation was related to the virulence of C. burnetii. Avirulent variants of the Nine Mile
strain poorly induced the formation of cytonemes compared to the virulent Nine Mile
strain (Fig. 2D). Interestingly, the Guyana strain induced a signiﬁcant increase of
cytonemes formation compared to the PMA control (Fig. S2).
As the formation of cytonemes was observed with a MC line, we wondered whether
primary MCs responded similarly to C. burnetii. Therefore, we puriﬁed MCs from
placenta, a tissue for which C. burnetii has a strong tropism (20). The placental MCs
(pMCs) were identiﬁed by ﬂow cytometry using FcR1/CD117 (Fig. S3A) and tryptase
staining (Fig. S3B). These pMCs were characterized by an ovoid nucleus, an irregular
membrane, a metachromatic staining of granules, and the presence of several tryptase-
FIG 2 C. burnetii-induced formation of cytonemes. (A) Cytonemes (white arrows, distance 208.4 m) and pseudopods
(yellow arrow, distance 11.1 m) stained with indicated markers were observed by confocal microscopy in MCs
stimulated for 3 h. (B) Tubulin (red), F-actin (green), and DNA (blue) staining were evaluated on cytonemes. (C) The
formation of cytonemes by MCs was quantiﬁed after stimulation with C. burnetii and expressed as a percentage
relative to PMA as the positive control. (D) The formation of cytonemes was quantiﬁed after a 3-h incubation of MCs
with virulent (Nine Mile) and avirulent (Nine Mile variant) bacteria. The results are expressed as a percentage relative
to PMA stimulation. (E) The release of cytonemes by pMCs stimulated by C. burnetii for 3 h was observed by confocal
microscopy, stained with the indicated markers. The results are expressed as the means plus SD for triplicate samples
from four independent experiments. *, P 0.05.
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positive cytoplasmic granules using MGG and toluidine blue (Fig. S3C), electron mi-
croscopy (Fig. S3D) and immunoﬂuorescence (Fig. S3E). As observed for the MC cell line,
C. burnetii also induced the formation of cytonemes in primary MCs (Fig. 2E). Alto-
gether, these ﬁndings show that C. burnetii induces the formation of cytonemes by MCs
and suggest that this phenotype depends, at least in part, on the virulence of the
bacteria.
MC cytonemes capture and kill bacteria. In order to understand the role of
cytonemes in the MC response to C. burnetii, we incubated MCs with bacteria. We found
that organisms were entrapped in cytonemes (Fig. 3A). After 3 h of contact between
MCs and bacteria, approximately 20% of C. burnetii organisms were already dead and
this number reached 80% after 6 h with the use of propidium iodide staining (Fig. 3B
and C), suggesting that cytonemes were involved in C. burnetii killing. As MCs are
known to secrete several antimicrobial products, we investigated their presence in
cytonemes. MCs were incubated with C. burnetii for 3 h, and the distribution of
antimicrobial agents, such as cathelicidin or neutrophil elastase, and extracellular
F-actin, was studied by confocal microscopy. We found that both cathelicidin and
FIG 3 Cytonemes trap and kill C. burnetii. HMC-1.2 cells were incubated with C. burnetii (Nine Mile strain)
for 3 h. (A) Bacteria (white arrows), colocalizing with cytonemes, appeared in yellow. (B) Bacteria
entrapped in cytonemes were indicated with white arrows. Their viability was studied by immunoﬂuo-
rescence microscopy: Live bacteria were stained with Sytox 9 and appeared in green, whereas dead
bacteria were stained with propidium staining and appeared in red. (C) The viability of bacteria
entrapped in cytonemes was quantiﬁed at 3 and 6 h p.i. (D) Cathelicidin and neutrophil elastase were
stained with speciﬁc Abs and were observed in red on MC cytonemes infected by C. burnetii with F-actin
labeled in green and DNA in blue. (E) The percentage of cytonemes induced by heat-inactivated bacteria
is expressed relative to the number of cytonemes induced by living bacteria. (F) The heat-inactivated
bacteria were labeled in red within MCs (white arrows). F-actin and DNA are shown in green and blue,
respectively. Data are the means plus SD for triplicate samples from three independent experiments. **,
P 0.01.
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neutrophil elastase colocalized with cytonemes (Fig. 3D), demonstrating that cy-
tonemes were armed to kill entrapped bacteria.
Second, we wondered whether cytonemes may protect MCs by avoiding the
internalization of virulent organisms. When MCs were incubated with heat-inactivated
C. burnetii instead of living bacteria, cytoneme formation was signiﬁcantly (P  0.0042)
reduced (Fig. 3E). Interestingly, we found that heat-inactivated bacteria were found
inside MCs (Fig. 3F), suggesting that cytoneme formation was associated with restricted
uptake of bacterial pathogens. Taken together, these results highlight the role of
cytonemes in killing virulent C. burnetii and represent another way other than phago-
cytosis in MCs.
Speciﬁc transcriptomic signature of C. burnetii-stimulated MCs. To understand
the molecular pathways involved in the formation of MC cytonemes, we studied the
transcriptional signature of MCs stimulated with C. burnetii by whole-genome microar-
ray. Hierarchical clustering revealed a speciﬁc pattern for MCs stimulated with virulent
bacteria that induced the formation of cytonemes, whereas MCs stimulated with an
avirulent variant clustered with unstimulated MCs (Fig. 4A). Principal-component anal-
ysis conﬁrmed that the signatures of MCs, stimulated with virulent and avirulent
bacteria, were clearly distinct (Fig. 4B). We found that 56 genes were differentially
expressed in response to C. burnetii, and most of these genes were upregulated in
response to virulent organisms, whereas downregulated genes were prominent in
response to the avirulent variant (Fig. 4C). Genes involved in several biological pro-
cesses were enriched using the Gene Ontology (GO) Consortium approach. They
included genes involved in cytoskeleton organization, cytokine-mediated signaling,
immune response, metabolic process, ion transport, transcription, apoptosis, cell ad-
hesion, cell-cell signaling, and cell projection (Fig. 4D). Therefore, to validate our
ﬁndings, we selected 10 genes (TMEM231, OCRL, CYLD, IL36G, TRIM62, LNX1, DST, PRRG1,
CENPJ, and RALGPS2) for which we assessed the modulation by qRT-PCR (see Table S2
in the supplemental material).
Interaction of CD36 with TLR4 in C. burnetii cell infection. Among the modulated
genes, we found that the gene encoding CD36 was found in three GO terms, including
cell projection, immune response, and cytoskeleton organization, and its expression
was upregulated in response to virulent bacteria compared to the avirulent variant
(Fig. 4E). The analysis of CD36 expression by qRT-PCR and ﬂow cytometry conﬁrmed
microarray data and showed that CD36 expression was increased only in MCs stimu-
lated with virulent bacteria (Fig. 5A and B). The confocal microscopy analysis revealed
that CD36 was overexpressed as membrane clusters in MCs stimulated with C. burnetii
(Fig. 5C). In addition, CD36 colocalized with C. burnetii at the surfaces of MCs (Fig. 5D).
As CD36 is known to cooperate with TLRs to clear microbial infection (21) and TLR4 has
been involved in actin remodeling in myeloid cells during C. burnetii infection (22), we
investigated the expression of TLR2 and TLR4 in stimulated MCs. The expression of the
TLR4 gene, but not that of the TLR2 gene, was dramatically upregulated in response to
C. burnetii, as measured by qRT-PCR (Fig. 5E) and ﬂow cytometry (Fig. 5F). In a second
step, we wondered whether CD36 and TLR4 were associated in MCs stimulated by C.
burnetii. Image overlay obtained by confocal microscopy showed that membrane CD36
and TLR4 colocalized at the surfaces of MCs incubated with C. burnetii (Fig. 5G). The
direct interaction between CD36 and TLR4 was then assessed by immunoprecipitation
experiment. We found that CD36 immunoprecipitated with TLR4 with a maximal
intensity 1 h after incubation of MCs with C. burnetii (Fig. 5H). The cross talk between
CD36 and TLR4 was further conﬁrmed by inhibition experiments. First, inhibition of
CD36 with blocking Abs (Fig. 5J) or transfection of MCs with a siRNA directed
against CD36 (Fig. S4), signiﬁcantly reduced the expression of TLR4 in stimulated MCs
(Fig. 5I). In addition, polymyxin B, an inhibitor of LPS binding, reduced TLR4 and CD36
expression of C. burnetii-stimulated cells. Finally, in TLR4-deﬁcient BMdMCs stimulated
by C. burnetii, the expression of CD36 was severely impaired compared to wild-type
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FIG 4 Transcriptional signature of MCs in response to C. burnetii. MCs were stimulated with C. burnetii (50 bacteria per cell) or left untreated for 8 h,
and the total RNA was extracted prior to microarray analysis. (A) Up- and downregulated genes are indicated in red and green, respectively. (B) The
(Continued on next page)
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BMdMCs (Fig. 5K). These results indicated a direct cooperation between TLR4 and CD36
in the response of MCs to C. burnetii.
Role of CD36/TLR4 complex in cytoneme formation. Since the CD36/TLR4 coop-
eration is initiated by the interaction of C. burnetii with MCs, we wondered whether the
CD36/TLR4 complex was involved in the formation of cytonemes. We therefore mea-
sured the cytoneme formation in response to C. burnetii in the presence of CD36
inhibitors. CD36 siRNA or CD36 blocking Abs inhibited cytoneme formation (Fig. 6A).
Similarly, polymyxin B that inhibited CD36 expression (Fig. 5I) also prevented the
formation of cytoneme. Finally, in TLR4-deﬁcient BMdMCs stimulated by C. burnetii, an
inhibition of 85% of cytoneme formation was observed (Fig. 6B). We then conﬁrmed
these results in primary MCs and showed that the treatment of pMCs with polymyxin
B or CD36 blocking Abs inhibited cytoneme formation (Fig. 6C). Taken together, these
results indicate that the release of cytoneme by MCs depends on cooperation between
CD36 and TLR4 in response to the challenge of C. burnetii.
DISCUSSION
We have demonstrated here an antibacterial mechanism of MCs based on cy-
tonemes that had never been reported before. It is established that bacteria are killed
by innate immune cells via numerous intra- and extracellular mechanisms. The former
are based on phagocytosis and phagosomal maturation, whereas the latter involve the
formation of ETs and the release of bactericidal compounds (23). Microorganisms,
including intracellular bacteria, have developed various strategies to subvert innate
immune responses. Indeed, C. burnetii successfully infects macrophages by controlling
phagocytosis and phagosome biogenesis (15, 24). We observed that MCs were able to
kill C. burnetii without internalizing it, suggesting an extracellular microbicidal mecha-
nism. This result is markedly distinct from S. aureus, which is killed by MCs via
internalization and ET formation (6). While C. burnetii induces the formation of ETs as
efﬁciently as S. aureus in neutrophils, C. burnetii is a poor inducer of ETs in MCs, which
appeared insufﬁcient to kill bacteria.
We also provided evidence that MCs use cytonemes for a microbicidal effect toward
C. burnetii. Cytonemes were initially associated with cell-cell communication (25, 26).
Although these cytoskeletal structures may participate in host defense, their speciﬁc
antimicrobial role has not been described thus far. Cytonemes have been implicated in
cell-to-cell spreading of virions, such as human immunodeﬁciency virus type 1 and
human T cell leukemia virus type 1 (HTLV-1) (27, 28, 29). Recently, Hashimoto et al.
reported that macrophage cytonemes enable the rapid transfer of HTLV-1 to surround-
ing cells (30). In contrast, neutrophil cytonemes are involved in the tethering of
bacteria, such as S. aureus, Salmonella enterica serovar Typhimurium, and Helicobacter
pylori. This capture of bacteria by neutrophil cytonemes allows internalization and
subsequent intracellular destruction (31). The microbicidal activity of neutrophil cy-
tonemes is probably based on the release of bactericidal molecules, such as lactoferrin,
lipocalin, myeloperoxidase, defensins, and cathepsin G (32). We reported here that
cytonemes entrapped C. burnetii and reduced its viability. The latter response is likely
mediated by elastase and cathelicidin, which colocalized with bacteria within cy-
tonemes. We also discovered that cytoneme-mediated killing of C. burnetii is associated
with the absence of phagocytosis, whereas cytonemes and phagocytosis are associ-
ated, during the interaction of S. aureus, with MCs. The dissociation of cytoneme
formation from phagocytosis was related to bacterial viability, since inactivated bacteria
were internalized and did not induce signiﬁcant cytoneme formation. The prevention
FIG 4 Legend (Continued)
relative distance between MCs stimulated with virulent C. burnetii (red), avirulent bacteria (green), or resting cells (blue) was assessed using
principal-component analysis. (C) Venn diagrams showed the distribution of upregulated (left) and downregulated (right) genes in MCs stimulated with
virulent C. burnetii (red) or avirulent variants (green). (D) Transcriptional analysis of modulated genes revealed several GO terms of biological process.
(E) A modular analysis of the cell projection, immune response, and cytoskeletal organization of GO terms showed the genes involved and their
modulation (up- and downregulation in red and blue, respectively).
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FIG 5 Involvement of CD36 and TLR4 in the response of MCs to C. burnetii. MCs were stimulated with C. burnetii
or left untreated, and the modulation of the CD36 and TLR4 genes or encoded proteins was determined. (A) The
expression of the gene encoding CD36 was evaluated in MCs stimulated by C. burnetii for 8 h and normalized to
the value for unstimulated cells. (B) The expression of CD36 protein was determined by ﬂow cytometry with
FITC-conjugated anti-CD36 on MCs stimulated with C. burnetii virulent and avirulent variants for 3 h. The results are
expressed as mean ﬂuorescence intensity. (C) Confocal microscopy revealed that the expression of CD36 (green)
was essentially expressed at the membrane. (D) The staining of CD36 (green) and C. burnetii (red) showed that they
colocalized (in yellow) at the MC membrane. (E) The expression of TLR2 and TLR4 transcripts was evaluated in MCs
stimulated by C. burnetii for 8 h by qRT-PCR and normalized to the value for unstimulated cells. (F) The modulated
expression of TLR4 protein in response to C. burnetii was determined by ﬂow cytometry and expressed as mean
ﬂuorescence intensity. (G) Confocal microscopy showed that TLR4 (red) and CD36 (green) colocalized (yellow) in
C. burnetii-stimulated MCs (DNA appeared in blue). (H) MCs were stimulated with C. burnetii for different periods.
Immunoprecipitations were immunoblotted with TLR4, CD36, or irrelevant Abs. (I and J) The expression of the CD36
(I) and TLR4 (J) genes was evaluated by qRT-PCR in MCs stimulated with C. burnetii for 8 h and treated with CD36
blocking Abs or polymyxin B or after siRNACD36 transfection. The results are normalized to the values for untreated
MCs. (K) The expression of CD36 gene expression was assessed in TLR4/ BMdMCs and normalized to the value
(Continued on next page)
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of phagocytosis in MCs is an active process reminiscent of what we reported in
macrophages and monocytes infected with virulent C. burnetii (19, 33). Indeed, C.
burnetii induced cytoskeletal reorganization of macrophages, such as F-actin protru-
sions, which was associated with phagocytosis prevention (10, 22). Manipulation of the
cytoskeleton organization in macrophages restores phagocytosis, thus establishing a
direct link between cytoskeleton modulation and phagocytosis interference (33, 34).
We hypothesize that C. burnetii-induced cytonemes alert the immune system since it
has been reported that externalized F-actin acts as a danger signal (35). Finally, in line
with Manfredi et al. who proposed a choice between phagocytosis and generation of
ETs for neutrophils during inﬂammation and infection (36), we think that MCs make a
choice between MC formation and phagocytosis in the context of C. burnetii infection.
Our study also described that a functional cooperation between CD36 and TLRs is
necessary for cytoneme formation. Indeed, we provide evidence that CD36 associates
with TLR4, thus forming a molecular complex that is involved in the production of
cytonemes and entrapping C. burnetii. This is consistent with previous reports in which
CD36 mediated signal transduction for TLR4 (37, 38, 39). The role of CD36 in the
immune response to microorganisms remains unclear. Some studies evoked a direct
role of CD36 in inﬂammatory response or in pathogen recognition (40, 41). Indeed,
Stuart et al. reported that CD36 may be a bacterial receptor for S. aureus, its cytoplasmic
C-terminal extremity being involved in bacterial internalization (42). The transfection of
CD36 into HeLa cells enhances the uptake of bacteria, including Escherichia coli,
Klebsiella pneumoniae, S. Typhimurium, S. aureus, and Enterococcus faecalis (40). In
addition, CD36 is involved in the internalization of LPS by endothelial or MCs (25, 43,
FIG 5 Legend (Continued)
for wild-type BMdMCs. Data are the means plus SD for triplicate samples from four independent experiments. *,
P 0.05; **, P 0.01.
FIG 6 CD36/TLR4 cooperation. MCs were stimulated with C. burnetii for 3 h. (A) The percentage of
cytonemes was calculated after treatment of stimulated MCs during 10 min with MDC, polymyxin B,
CD36 blocking Abs, or after siRNA CD36 transfection compared to untreated cells. (B) The percentage of
cytonemes was calculated in TLR4-deﬁcient BMdMCs compared to wild-type BMdMCs. (C) Placental MCs
from healthy donors were collected after enzymatic digestion, Percoll cushion procedure, and magnetic
selection. The release of cytonemes by pMCs stimulated by C. burnetii for 3 h were quantiﬁed after
polymyxin B sulfate or CD36 blocking antibody treatments. Data are the means  SD for triplicate
samples and are representative of four independent experiments. **, P 0.01.
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44). Future studies are required to address the precise mechanism underlying CD36/
TLR4 cross talk during C. burnetii infection.
The formation of cytonemes in response to C. burnetii was not restricted to MC lines
or murine MCs derived from bone marrow. It was also observed in primary MCs isolated
from the human placenta. C. burnetii is known for its tropism for placenta tissue, and
Q fever is a major risk for pregnancy and impaired fetal development (20). We
previously described that C. burnetii interacts with dendritic cells from placenta and
replicates in trophoblasts (11, 45). Here, we report that MCs from placenta present an
extracellular mechanism to kill bacteria in the early phases of C. burnetii infection. The
role of MCs in promoting host resistance in bacterial infection is documented (46–48).
Thus, we can speculate that during C. burnetii infection, MCs play a role of protection
at the placenta level by intercepting extracellular pathogens and limiting abortion. This
ﬁnding may also explain why trophoblasts constitute a niche for C. burnetii (11).
However, these hypotheses have to be clariﬁed by careful examination of organism
distribution in the naturally infected placenta in order to provide insights into the roles
of individual cell types in abortion during Q fever.
In conclusion, our data described a new extracellular bactericidal mechanism based
on the release of cytonemes by MCs. Cytonemes were involved in the capture of
virulent C. burnetii and the destruction of entrapped bacteria mediated by antimicrobial
peptides. We also showed that the formation of cytonemes requires the CD36/TLR4
complex. This report opens new perspectives in the antimicrobial activity of MCs and
provides new insights into the role of cytonemes in the immune response.
MATERIALS AND METHODS
Cells. The human mast cell line HMC-1.2 was generously provided by M. Arock (Paris, France) and
cultured in Iscove’s modiﬁed Dulbecco’s medium (IMDM) (Life Technologies) supplemented with 10%
fetal bovine serum (FBS), 100 IU/ml penicillin, and 50 g/ml streptomycin (Life Technologies) at 37°C. In
some experiments, placental MCs (pMCs) were isolated. Placenta from at-term healthy women were
included after providing written informed consent and after approval was granted from the Comité
d’Ethique d’Aix Marseille Université (number 08-012). Placenta tissue was digested with trypsin, and the
cell suspension was deposited on a 25 to 60% Percoll cushion and centrifuged as previously described
(49). Placental cells were collected, and pMCs were enriched by positive selection after FcR1/CD117
staining (Miltenyi Biotec). In some experiments, bone marrow-derived MCs (BMdMCs) were differentiated
as previously described (50). Brieﬂy, wild-type mice were obtained from Charles River Laboratories, and
TLR4-deﬁcient mice were generously provided by L. Alexopoulou (Marseille, France). Bone marrow cells
were ﬂushed and incubated with IMDM containing 15% FBS, 10 ng/ml IL-3, and 10 ng/ml stem cell factor
(Miltenyi Biotec). After 4 weeks of culture, the differentiation into BMdMCs was checked by ﬂow
cytometry using CD117 and FcR1 as speciﬁc markers. About 98% of cultured cells were BMdMCs (data
not shown). Human neutrophils and monocytes were isolated from blood samples from three healthy
donors (Établissement Français du Sang, Marseille, France) using Percoll or Ficoll gradient, respectively,
and incubated in RPMI 1640 (Life Technologies), as previously described (17).
Bacteria. Bacteria (Nine Mile and Guyana strains of C. burnetii) were prepared as previously reported
(12). Avirulent variants of Nine Mile bacteria were obtained after repeated passages in L929 cells. Bacteria
were stored at 80°C, their concentration was determined by Gimenez staining, and bacterial viability
was assessed using the live/dead BacLight bacterial viability kit (Molecular Probes, Life Technologies)
(51). Bacteria were inactivated at 95°C for 30 min. S. aureus (ATCC 25923) bacteria were grown on blood
agar plates (bioMérieux) and quantiﬁed by ﬂow cytometry (FACS BD Fortessa).
Cell stimulation. MCs and neutrophils (1 106 cells/well) were incubated in 24-well plates pre-
treated with ﬁbronectin (1 mg/well; Life Technologies) for 3 h. Adherent cells were stimulated with
100 g/ml LPS, 25 nM phorbol-12-myristate-13-acetate (PMA) (MP Biomedicals), or bacteria (bacterium-
to-cell ratio of 25 and 50 bacteria per cell for S. aureus and C. burnetii, respectively) at 37°C. The roles of
CD36 and TLR4 were studied using MCs pretreated with 5 g/ml CD36-blocking antibodies (Abs) (mouse
IgG2a; Thermo Fisher Scientiﬁc) or 10 g/ml of the TLR4 inhibitor polymyxin B sulfate (Sigma-Aldrich) for
10 min.
Bacterial detection. C. burnetii organisms were detected by quantitative PCR (qPCR) and immuno-
ﬂuorescence as previously described (12). The total DNA was extracted using the NucleoSpin kit
(Macherey-Nagel). Quantitative PCR was performed using Sybr Green Technologies using a CFX (Bio-Rad)
with 5 l of DNA and speciﬁc primers targeting C. burnetii com1 gene: sense (5=-GCACTATTTTTAGCCG
GAACCTT-3=) and antisense (5=-TTGAGGAGAAAAACTGGATTGAGA-3=). C. burnetii organisms were also
detected by immunoﬂuorescence. In brief, MCs were ﬁxed with 3% paraformaldehyde, permeabilized
with 0.1% Triton X-100 for 5 min, and incubated with a 1/100 dilution of Q fever patient serum (11). After
washing, MCs were incubated with Alexa Fluor 647-conjugated Abs. S. aureus was labeled with the
ﬂuorochrome DID (4-(4-(dihexadecylamino)styryl)-N-methylpyridinium iodide) (Thermo Fisher Scientiﬁc)
for 20 min at 37°C.
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Cytonemes and extracellular traps. The quantiﬁcation of ET release was based on the evaluation
of the area of labeled extracellular DNA ﬁlaments using an Axio Scan coupled with Hamamatsu sCOMS
Flash 4 camera (Zeiss). The area of extracellular DNA of ETs was quantiﬁed on ﬁve different ﬁelds as
previously described (52, 53). The results are expressed as a percentage relative to the PMA-stimulated
cells as a positive control (cells stimulated with PMA) (54). Similarly, the evaluation of cytoneme
formation over time was realized by assessment of area of extracellular F-actin ﬁlaments and expressed
as a percentage relative to the PMA control, as depicted in Fig. S5 in the supplemental material. In some
experiments, stimulated MCs were treated with 50 U/ml DNase (Sigma-Aldrich) for 30 min at the end of
the experiment to disrupt ETs as previously described (17). The cytonemes were quantiﬁed using a similar
method based on the release of extracellular F-actin labeled with phalloidin-488. To inhibit the formation
of cytonemes, MCs were pretreated with 10 mM methyl--D-cyclodextrin (MDC) (Sigma-Aldrich) for 10
min as previously described (18).
MC phenotyping and cytoneme staining. MCs were incubated with Abs directed against CD36
(mouse IgG1; Beckman Coulter), CD117 (mouse IgG1; Beckman Coulter), FcR1 (mouse IgG1; Bühlmann
Laboratories), TLR4 (mouse IgG1; BD Pharmigen), tryptase (mouse IgG1; Thermo Fisher Scientiﬁc),
neutrophil elastase (rabbit IgG; Abcam), cathelicidin (rabbit IgG; Thermo Fisher Scientiﬁc), tubulin (mouse
IgG1; Thermo Fischer Scientiﬁc), or appropriate isotype controls for 1 h. After the cells were washed,
secondary Abs conjugated to Alexa Fluor 647 goat anti-rabbit or anti-mouse IgG1 (Life Technologies)
were added to MCs for 30 min. Stained cells were then analyzed by confocal microscopy using an LSM
800 Airyscan confocal microscope (Zeiss) or by ﬂow cytometry (10,000 events/acquisition) using a FACS
BD Fortessa ﬂow cytometer (BD Biosciences). The results of ﬂow cytometry are expressed in mean
ﬂuorescence intensity (MFI), as calculated by the FlowJo software vX.0.7.
Microarray and data analysis. MCs (1 106 cells/well) were stimulated or not stimulated with C.
burnetii for 8 h, and the total RNA was extracted using a RNeasy Mini kit followed by DNase treatment
(Qiagen) to perform microarray experiment as described above (11). The 4X44K Human Whole Genome
G4112F microarrays (Agilent Technologies), representing 45,000 probes, were used. Sample labeling and
hybridization were performed using one-color microarray-based gene expression analysis. Four samples
per experimental condition were included in the analysis. Slides were scanned with a pixel size of 5-m
resolution with a G2505C DNA microarray scanner (Agilent Technologies), and data were analyzed with
Feature Extraction Software 10.5.1. The selected probes were ﬁltered for differentially expressed genes using
an absolute fold change (FC) of 1.5. The functional annotation was performed using DAVID Bioinformatics
Resources (55, 56). The modulation of some genes was conﬁrmed by quantitative reverse transcription-PCR
(qRT-PCR) using the MMLV-RT kit (Life Technologies) and SYBR Green Fast Master Mix (Roche Diagnostics).
Conﬁrmation experiments were conducted using speciﬁc primers designed with Primer3 software (Table S1).
The results were normalized using the housekeeping gene actb gene encoding -actin and are expressed as
themean of FC 2ΔΔCt in which ΔΔCt (CtTarget CtActin)assay (CtTarget CtActin)control. The threshold cycle
(Ct) was deﬁned as the number of cycles required to detect the ﬂuorescent signal. The expression of genes
was considered modulated when the FC was 1.5.
Small interference RNA transfection (siRNA). siRNAs directed against CD36 were purchased from
Ambion (Life Technologies) and constructed with the following target sequences: sense (5=-CACUAUC
AGUUGGAACAGAtt-3=) and antisense (5=-UCUGUUCCAACUGAUAGUaa-3=). HMC-1.2 cell line (1 106
cells/well) were grown to 80% conﬂuence and transfected with 5 nM CD36 siRNA for 6 h using
Lipofectamine 2000 (Life Technologies), according to the manufacturer’s instructions (Life Technologies).
Immunoprecipitation. HMC-1.2 cells (1 107 cells) were treated with C. burnetii (50 bacteria per cell)
for the indicated periods, washed in ice-cold phosphate-buffered saline and lysed in 20 mM Tris-HCl (pH
7.4), 200 mM NaCl, 1 mM EDTA, 1% Triton X-100 with protease inhibitors as previously described (41).
Protein lysate was incubated with 4 g of anti-human CD36 (Thermo Fisher Scientiﬁc) or control IgG
(mouse IgG2a; Beckman Coulter) overnight at 4°C and then incubated with protein G-Sepharose beads
(Sigma-Aldrich) for 3 h at 4°C. Immunoblotting was performed on 10% polyacrylamide gels using
anti-CD36 (rabbit IgG; Thermo Fisher Scientiﬁc) and anti-TLR4 (rabbit IgG; Thermo Fisher Scientiﬁc) Abs,
and the signal were recorded using the ECL Plus reagent (Thermo Fisher Scientiﬁc).
Statistical analysis. Data were analyzed with GraphPad Prism 5.0c and Student’s t test. A P value of
0.05 was considered statistically signiﬁcant.
Accession number(s). The data have been deposited in NCBI’s Gene Expression Omnibus (57) and
are accessible though GEO series accession number GSE111971.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.02669-18.
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